Illumina expands Billion Cell Atlas program with new AI drug developers

Summary

Illumina announced expansion of its Billion Cell Atlas alliance program with three new AI-native drug developer members to advance precision medicines. The program aims to leverage unprecedented data scale to accelerate drug development to regulatory approval.